Trinity Biotech plc Sustainability Profile
Trinity Biotech plc, a leading player in the biotechnology sector, is headquartered in Ireland (IE) and operates extensively across Europe, the Americas, and Asia. Founded in 1992, the company has established itself as a pioneer in the development and manufacturing of diagnostic products, particularly in the fields of infectious diseases, diabetes, and autoimmune disorders. Trinity Biotech's core offerings include a diverse range of diagnostic tests and instruments, renowned for their accuracy and reliability. The company’s commitment to innovation has led to significant milestones, including the introduction of cutting-edge point-of-care testing solutions. With a strong market position, Trinity Biotech is recognised for its contributions to improving patient outcomes and advancing healthcare diagnostics globally.
DitchCarbon Score
How does Trinity Biotech plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Trinity Biotech plc's score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Trinity Biotech plc's reported carbon emissions
Trinity Biotech plc, headquartered in Ireland (IE), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. As of now, Trinity Biotech plc has not established any science-based targets or commitments to reduce emissions, nor does it inherit emissions data from a parent company. The lack of reported emissions and climate initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many companies are increasingly focusing on sustainability and carbon reduction, making it essential for Trinity Biotech plc to consider establishing measurable targets and commitments to align with global climate goals.
How Carbon Intensive is Trinity Biotech plc's Industry?
How Carbon Intensive is Trinity Biotech plc's Location?
Trinity Biotech plc's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Trinity Biotech plc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
